Registration: 
CPS Members: FREE
Non-members: $10.00

REGISTER HERE

Pulmonary arterial hypertension (PAH) is a rare disease with significant consequences, including serious functional impairment and premature death. If left untreated, PAH is rapidly fatal. Fortunately, over the past decade, the knowledge and understanding of this disease has greatly expanded. Furthermore, the availability of effective and more convenient oral and inhaled medications has allowed clinicians to better individualize therapy to meet patient treatment goals. Though there is no cure for PAH, effective treatment can significantly slow disease progression and clinical worsening. Given the serious nature of this disease and its rapid progression, optimal treatment selection is essential. 

CEs: 1.0

Learning Objectives:

• Differentiate among the current PAH medications based on pharmacology, dosing, safety, and efficacy 
• Explain evidence-based approaches aimed at individualizing therapy for PAH patients based on patient factors and disease state 
• Identify strategies to improve collaboration and communication among interprofessional team members to help transition PAH patients between home/community and acute care settings

Accreditation:

Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.
ACPE UAN:  0473-9999-21-002-L01-P          
Activity type: Knowledge-based

View Program Flyer